Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.01
+0.01 (0.21%)
At close: Sep 14, 2026, 4:00 PM EDT
7.01
0.00 (0.00%)
After-hours: Sep 14, 2026, 4:15 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $726.97 million as of September 14, 2026. Its market cap has increased by 89.36% in one year.
Market Cap
726.97M
Enterprise Value
419.72M
1-Year Change
89.36%
Ranking
Category
Stock Price
$7.01
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $726.97M, an increase of 82.78%. That is a compound annual growth rate of 13.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 726.97M | 110.05% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharming Group | 761.51M |
| Annexon | 746.94M |
| Monopar Therapeutics | 740.08M |
| 4D Molecular Therapeutics | 727.57M |
| Achieve Life Sciences | 726.49M |
| MapLight Therapeutics | 722.48M |
| DBV Technologies | 720.55M |
| CytomX Therapeutics | 716.89M |